Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Tobacco Approach Avoidance Training for Adolescent Smokers-1

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Behavioral: AAT experiment

First Posted Date: 2012-06-21

Last Posted Date: 2013-08-21

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT01625767

Locations: 🇺🇸
Yale University, School of Medicine, Dpeartment of Psychiatry, New Haven, Connecticut, United States

Tobacco Approach Avoidance Training for Adolescent Smokers-2

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Behavioral: AAT-placebo
Behavioral: AAT-experiment

First Posted Date: 2012-06-21

Last Posted Date: 2014-01-20

Lead Sponsor: Yale University

Target Recruit Count: 66

Registration Number: NCT01625637

Locations: 🇺🇸
Yale University, School of Medicine, Department of Psychiatry, New Haven, Connecticut, United States

Varenicline on Reward Responses and Cognition in Adolescent Smokers

Phase 1

Completed

Conditions: Tobacco Use Disorders

Interventions: Drug: Placebo
Drug: Varenicline

First Posted Date: 2012-06-20

Last Posted Date: 2014-02-03

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT01624428

Locations: 🇺🇸
Substance Abuse Center, New Haven, Connecticut, United States

Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal

Phase 2

Completed

Conditions: Cannabis Dependence

Interventions: Drug: PF-04457845
Drug: Placebo

First Posted Date: 2012-06-13

Last Posted Date: 2023-02-23

Lead Sponsor: Yale University

Target Recruit Count: 70

Registration Number: NCT01618656

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Web-based CBT4CBT for Alcohol

Not Applicable

Completed

Conditions: Alcohol Abuse or Dependence

Interventions: Behavioral: Web-based CBT4CBT for alcohol plus TAU
Behavioral: Standard Treatment as Usual (TAU)
Behavioral: Web-based CBT with minimal clinical contact

First Posted Date: 2012-06-08

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 68

Registration Number: NCT01615497

Locations: 🇺🇸
Substance Abuse Treatment Unit (SATU), New Haven, Connecticut, United States

The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects

Not Applicable

Completed

Conditions: NMDA Receptor Function

Interventions: Drug: Guanfacine
Drug: Placebo

First Posted Date: 2012-05-17

Last Posted Date: 2017-08-21

Lead Sponsor: Yale University

Target Recruit Count: 16

Registration Number: NCT01600885

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸
Yale Magnetic Resonance Research Center, New Haven, Connecticut, United States
🇺🇸
Veterans Affairs Hospital, West Haven, Connecticut, United States

Cannabinoid Modulation of Pain

Early Phase 1

Completed

Conditions: Pain

Interventions: Other: Thermal
Other: Electrical
Other: Capsaicin
Drug: THC
Drug: Placebo

First Posted Date: 2012-05-10

Last Posted Date: 2022-03-09

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT01595620

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Combination SBIRT for Emergency Department Patients Who Drink and Smoke

Early Phase 1

Completed

Conditions: Smoking
Drinking

First Posted Date: 2012-05-09

Last Posted Date: 2020-06-26

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT01595178

Locations: 🇺🇸
Yale New Haven Hospital Emergency Department, New Haven, Connecticut, United States

The Effects of ∆-9-THC and Naloxone in Humans

Early Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo
Drug: Naloxone
Drug: Delta-9-THC

First Posted Date: 2012-05-04

Last Posted Date: 2022-03-09

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT01591629

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Yoga for Pain and Opioid Dependence

Phase 1

Completed

Conditions: Chronic Pain
Opioid Addiction

Interventions: Other: Yoga
Behavioral: Educational Counseling

First Posted Date: 2012-05-02

Last Posted Date: 2015-09-25

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT01590251

Locations: 🇺🇸
MRU, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy